DaVita: Nocturnal In-center HD Beats Standard HD

A study of 2,747 patients treated at all of the 176 DaVita in-center nocturnal HD (INHD) programs in 2017 and 2018 found an array of benefits. INHD patients had higher solute clearance, gentler water removal—for less organ stunning, higher serum albumin, and less hospitalization than those on standard HD, revealed a poster at ASN Kidney Week.

Read the full article » | Posted 11-16-2019

Related Articles

• First Diality Patient Dialysis on New FDA-approved Moda-flx HD Machine Posted 01-13-2025
• Baxter will Provide a Supply Update in Early 2025 Posted 01-13-2025
• Baxter Plant Expected to be at 100% by the End of the Year Posted 12-11-2024
• PD patient and restaurant owner in Wichita worries about Baxter’s PD fluid shortage Posted 11-21-2024